Cosmetic and personal care products occupy an unusual regulatory space in the United States. Unlike drugs, they don’t require FDA approval before they can be sold. But that lighter pre-market pathway doesn’t mean lighter responsibility.
Under US law, cosmetics simply cannot be “adulterated” or “misbranded,” and companies that manufacture or distribute them are legally accountable for ensuring their products are free of harmful microorganisms. FDA doesn’t need to approve a product to take action against it after the fact.
That distinction matters more than it might seem. A product can clear every internal quality check, launch successfully, and still trigger a recall months later if its microbiological testing program wasn’t rigorous enough. The consequences of getting this wrong extend well beyond a single batch: contamination with bacteria, yeast, or mold can lead to consumer infections or skin irritation, physicochemical breakdown of the product itself, FDA scrutiny, and lasting damage to brand reputation.
Recent market withdrawals tell the story clearly, with recalls tied to hand sanitizers and wipes contaminated with Burkholderia cepacia complex and Ralstonia pickettii, lotion contaminated with Pluralibacter gergoviae, and shampoo products contaminated with E. coli and Pseudomonas aeruginosa.
So how do microorganisms get into cosmetic products in the first place? The entry points are more varied than most brands assume. Contaminated raw materials (including the water used in formulation), unsanitary manufacturing conditions, natural ingredients that lack an effective preservative system, packaging that doesn’t adequately protect the product, poor shipping or storage conditions, and even consumer handling, such as dipping fingers directly into a jar, can all introduce microorganisms.
Prevention requires addressing each of these points systematically, from manufacturing practices and equipment sanitization to the design and testing of the preservative system itself.
That preservative system is validated through Preservative Efficacy Testing (PET), which measures whether a product’s antimicrobial preservatives can inhibit the growth of microorganisms introduced during manufacturing or consumer use. Standard methods include USP <51>, ISO 11930, EP 5.1.3, and various Personal Care Product Council methods. A PET typically inoculates the product with a panel of standard test organisms, such as Staphylococcus aureus, Escherichia coli, Pseudomonas paraeruginosa, Candida albicans, and Aspergillus brasiliensis, then samples the product at set intervals to measure how effectively the preservative system reduces microbial load. It’s worth noting that simply loading a formula with excess preservative to compensate for poor manufacturing hygiene is not an acceptable workaround in the FDA’s eyes.
Beyond preservative testing, products and raw materials are also subject to Microbial Limit Testing, which quantifies total aerobic microbial count and total yeast and mold count, and screens for specified or objectionable organisms like E. coli, Staphylococcus aureus, Salmonella, and Pseudomonas aeruginosa. These tests are governed by harmonized standards including USP <61> and <62>, EP 2.6.12 and 2.6.13, and a set of ISO methods specific to cosmetic products.
None of this testing happens in a vacuum. An effective microbiological safety program also depends on an Environmental Monitoring Program that tracks air quality, surface cleanliness, and personnel practices within the manufacturing facility, along with Equipment Cleaning Validation to confirm that cleaning procedures consistently remove residues, contaminants, and microbes between production runs.
Taken together, these testing and monitoring programs form the backbone of consumer safety and brand integrity in the personal care industry. They’re not a regulatory formality. They’re the mechanism by which a brand can say, with evidence, that its product is safe.